If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

  • This share is currently suspended. It was suspended at a price of 305.00
  • There is currently no data for TET

Update on Site Relocation

22 Dec 2016 15:11

RNS Number : 6487S
Treatt PLC
22 December 2016
 

 

 

 

 

22 December 2016

TREATT PLC

 

Update on Site Relocation

 

Treatt Plc ('Treatt', the 'Company' or the 'Group'), the manufacturer and supplier of innovative ingredient solutions for the flavour, fragrance and FMCG industries announces that, further to the updates on the Group's proposed site relocation set out in the Company's results for the year ended 30 September 2016 announced on 29 November 2016, it has conditionally exchanged contracts on a ten acre plot of land on Suffolk Park being developed by Jaynic in Bury St Edmunds.

Completion of the purchase, the price of which is subject to contractual confidentiality, is conditional upon the vendor being granted outline planning permission, application for which is due to be made shortly.

The purchase of the land will be funded from existing resources and it is not anticipated that further major capital outlay will be required until later in calendar 2017.

Enquiries:

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Finance Director

 

Brokers

Investec Investment Banking

Patrick Robb +44 (0)20 7597 4000

David Anderson

 

Public relations

Davidson Ryan Dore

Lawrence Dore +44 (0)20 7520 9218

About the Group

Treatt is a global, independent supplier of innovative ingredient solutions for the flavour, fragrance and FMCG industries. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America, Africa and Asia and has manufacturing facilities in the UK, USA and Kenya. Its international foot print enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

Earthoil is the cosmetics ingredients division of Treatt, which specialises in pure and organic fair trade essential and cold pressed vegetable seed oils, offering a broad spectrum of natural raw materials for cosmetic applications.

 

For further information about the Group, visit www.treatt.com and www.earthoil.com.

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDELLFLQLFBFBD
Date   Source Headline
13th May 202610:19 amRNS20260512_TREATT PLC_8.5 EPT RI_UK_MLI
13th May 20269:34 amRNSForm 8.3 Treatt Plc
12th May 20263:07 pmRNSForm 8.3 - TREATT PLC
12th May 20262:44 pmRNSForm 8.3 TREATT PLC
12th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt PLC
12th May 202610:27 amRNSForm 8.3 Treatt plc
12th May 20267:00 amRNSPublication and Posting of Scheme Document
11th May 20265:38 pmRNSOpening Position Disclosure - Replacement
11th May 202612:06 pmRNSForm 8.3 TREATT PLC
11th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
11th May 202610:47 amRNS20260508_TREATT PLC_8.5 EPT RI_UK_MLI
11th May 202610:18 amRNSForm 8.3 Treatt Plc
8th May 20263:54 pmRNSHolding(s) in Company
8th May 20263:20 pmRNSForm 8.3 TREATT PLC
8th May 20263:20 pmRNSForm 8.3 - Treatt plc
8th May 202612:12 pmRNSForm 8.3 Treatt plc
8th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
8th May 202610:49 amRNS20260507_TREATT PLC_8.5 EPT RI_UK_MLI
8th May 20269:21 amGNWForm 8.5 (EPT/RI)-Treatt Plc
8th May 20269:21 amBUSForm 8.5 (EPT/RI)-Treatt Plc
8th May 20269:08 amRNSUpdate on Letters of Intent
7th May 20263:44 pmRNSForm 8.3 - Treatt PLC
7th May 20263:42 pmRNSForm 8.3 - Treatt PLC
7th May 20263:39 pmRNSForm 8.3 - Treatt PLC
7th May 20263:34 pmRNSForm 8.3 - Treatt PLC
7th May 20263:28 pmRNSForm 8.3 TREATT PLC
7th May 20263:25 pmRNSForm 8.3 - Treatt plc
7th May 20263:04 pmRNSForm 8.3 - Treatt PLC
7th May 20261:17 pmRNSForm 8.3 - Treatt plc
7th May 202612:20 pmRNSForm 8.3 Treatt plc
7th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
7th May 202611:44 amRNSOpening Position Disclosure
7th May 202610:37 amRNS20260506_TREATT PLC_8.5 EPT RI_UK_MLI
7th May 20267:00 amRNSUpdate on Letters of Intent
7th May 20267:00 amRNSForm 8.3 - Treatt plc - Replacement
6th May 20263:12 pmRNSForm 8.3 - TREATT PLC
6th May 20261:21 pmRNSForm 8.3 TREATT PLC
6th May 20261:17 pmRNSForm 8.3 - Treatt Plc
6th May 202612:18 pmRNSForm 8.3 Treatt plc
6th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
6th May 202611:34 amRNS20260505_TREATT PLC_8.5 EPT RI_UK_MLI
6th May 20267:00 amRNSUpdate on Letters of Intent
5th May 20263:17 pmRNSForm 8.3 - TREATT PLC
5th May 202612:22 pmRNSForm 8.3 Treatt Plc
5th May 202612:14 pmRNSForm 8.3 - Treatt PLC
5th May 202612:00 pmRNSForm 8.5 (EPT/RI) Treatt plc
5th May 20268:09 amRNSForm 8.3 TREATT PLC
5th May 20267:00 amRNSForm 8.5 (EPT/RI) - Treatt plc
1st May 20264:30 pmRNSUpdate on Letters of Intent
1st May 20263:50 pmRNSForm 8 (Opening Position Disclosure)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.